Stock listing
NASDAQ:PRDS Pardes Biosciences Inc Stock
Follow Pardes Biosciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PRDS
$2.16 USD
Close on Sep 8, 2023 · No longer trades
- Lowest – highest close
- $0.85 – $17.02 USDSince Feb 17, 2021 · lowest Nov 29, 2022 · highest Dec 30, 2021
Delisted NASDAQ:PRDS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PRDS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Owen Hughes Other companies: AnaptysBio, Inc. (Member of the Audit Committee · Since at least May 11, 2026); XOMA Royalty Corporation (Chief Executive Officer, Director · Since at least Nov 11, 2024); C4 Therapeutics, Inc. (Director · Since at least Nov 16, 2023); ImageneBio, Inc. (Director · Dec 14, 2022 – Jun 7, 2024 · Past); Cullinan Therapeutics, Inc. (President and CEO, Director · Jan 7, 2021 – Jan 12, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Sep 14, 2021 · Past); Radius Health, Inc. (Director · Apr 23, 2013 – Aug 15, 2022 · Past) | Director · Feb 16, 2021 – Dec 23, 2021 · Past |
| Thomas Wiggans Other companies: Pacira BioSciences, Inc. (Independent Director · Since at least Jun 9, 2026); Jasper Therapeutics, Inc. (Chairman of the Board · Since at least Nov 1, 2023); Annexon, Inc. (Director · Since at least Jul 23, 2020); Forma Therapeutics Holdings Inc (Director · Sep 7, 2020 – Oct 14, 2022 · Past); Somaxon Pharmaceuticals Inc (Director · Jun 11, 2008 – Jul 2, 2012 · Past); Sangamo Therapeutics, Inc. (Director · Jun 4, 2008 – Jun 1, 2011 · Past); Onyx Pharmaceuticals Inc (Director · Aug 29, 2007 – Oct 1, 2013 · Past) | Chief Executive Officer, Director · Mar 1, 2022 – Aug 31, 2023 · Past |
| Deborah M Autor Other companies: Hims & Hers Health, Inc. (Chief Policy Officer, Director · Since at least Nov 15, 2024); Amneal Pharmaceuticals, Inc. (Director · Since at least Jul 29, 2022) | Director · Dec 23, 2021 – Aug 31, 2023 · Past |
| Michael Varney Other companies: Erasca, Inc. (Chair of R&D, SAB Member and Board Director · Since at least Jul 15, 2021); Foundation Medicine Inc (Director · Apr 7, 2015 – Apr 7, 2015 · Past) | Director · Dec 23, 2021 – Aug 31, 2023 · Past |
| Brian Philippe Tinmouth Other companies: Scynexis, Inc. (Director · Since at least Jun 17, 2022) | Chief Bus. & Strategy Officer · Sep 14, 2022 – Sep 14, 2022 · Past |
| Daniel Dubin Other companies: Disc Medicine, Inc. (Director · Aug 11, 2020 – Aug 11, 2020 · Past) | Director · Feb 16, 2021 – Dec 23, 2021 · Past |
| Dennis D Ryan Other companies: Disc Medicine, Inc. (Chief Financial Officer · Aug 11, 2020 – Aug 11, 2020 · Past) | Chief Financial Officer · Feb 16, 2021 – Feb 16, 2021 · Past |
| Mark Auerbach Other companies: Assembly Biosciences, Inc. (Director · May 30, 2018 – May 17, 2019 · Past) | Director · Dec 23, 2021 – Aug 31, 2023 · Past |
| Sean Brusky Other companies: Prelude Therapeutics Incorporated (Chief Business Officer · Since at least Mar 5, 2026) | Chief Commercial Officer · Dec 23, 2021 – Feb 1, 2023 · Past |
Log in to ask 6ix AI your own questions about Pardes Biosciences Inc.